机构：[1]Hepatobiliary Surgery, The Second Affiliated Hospital of Jiaxing Medical College, Jiaxing, China[2]Pathology, Daping Hospital and Research Institute of Surgery, Army Medical University, Chongqing, China[3]Oncology, Sun Yat-sen University Cancer Hospital, Guangzhou, China[4]Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, China[5]Oncology, Fujian Cancer Hospital, Fuzhou, China[6]Oncology, The Second Affiliated Hospital of Medical College, Xi’an Jiaotong University, Xi’an, China[7]Radiotherapy, Xiamen Cancer Hospital, Xiamen, China[8]Oncology, The Third People’s Hospital of Zhengzhou, Zhengzhou, China[9]Oncology, Baotou Cancer Hospital, Baotou, China[10]Oncology, Peking University International Hospital, Beijing, China[11]Pathology, Daxing Teaching Hospital of Capital Medical University, Beijing, China[12]Oncology, Shanxi Dayi Hospital, Shanxi Academy of Medical Science, Taiyuan, China山西白求恩医院[13]Oncology, The First Hospital of Jilin University, Changchun, China[14]Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, China大连医科大学附属第一医院[15]Pathology, Fujian Cancer Hospital, Fuzhou, China[16]Chemotherapy, Zhejiang Cancer Hospital, Hangzhou, China浙江省肿瘤医院[17]Oncology, The Seven Medical Centre of Chinese PLA General Hospital, Beijing, China
第一作者机构：[1]Hepatobiliary Surgery, The Second Affiliated Hospital of Jiaxing Medical College, Jiaxing, China
推荐引用方式(GB/T 7714)：
Shen Y.,Fang S.,Cai X.,et al.Real-world fusion landscape in advanced Chinese pancreatic cancer using next generation sequecing: A multicenter study[J].ANNALS OF ONCOLOGY.2019,30:-.doi:10.1093/annonc/mdz431.009.
APA：
Shen, Y.,Fang, S.,Cai, X.,Fang, Y.,Lin, R....&Zhang, J..(2019).Real-world fusion landscape in advanced Chinese pancreatic cancer using next generation sequecing: A multicenter study.ANNALS OF ONCOLOGY,30,
MLA：
Shen, Y.,et al."Real-world fusion landscape in advanced Chinese pancreatic cancer using next generation sequecing: A multicenter study".ANNALS OF ONCOLOGY 30.(2019):-
医学